The role of pharmacopoeia in the context of globalization of world economies and its development prospects
Abstract
The article reviews the process of development and the role of national and regional pharmacopoeias in the context of globalization of world economies. Three major paths of globalization identified are: enlargement of national pharmacopoeias’ area of influence, formation of supranational (regional and supraregional) pharmacopoeias and harmonization of pharmacopoeias. The article draws a conclusion on interrelation of national and regional pharmacopoeias that aim to contribute to each other’s development. Harmonization of pharmacopoeias should follow the path of alignment of test methods and analytical procedures and at the same time accommodate national factors and priorities of countries that are involved in harmonization.
About the Authors
A. V. Titova
N. I. Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
N. P. Sadchikova
I. M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
References
1. Ovcharov EG. The global pharmaceutical industry (Current status and development trends in the context of globalization). Dr. Econ. Sci [dissertation]. Moscow; 2005 (in Russian).
2. Molvinskiy AV. Strategy of foreign companies on the Russian and global pharmaceutical markets. Issledovano v Rossii, 2001. Available from: http://zhurnal.ape.relarn.ru/articles/2001/057.pdf (in Russian).
3. Plaksina S. Taste of native pills. Ekspert—Ukraina 2006; ¹_27(78). Available from: http://www.expert.ru/printissues/uk- raine/2006/27/farmacevticheskiy_rynok (in Russian).
4. Mergers in the pharmaceutical sector: who, with whom and why. Provizor 2006; (11). Available from: http://www.provisor.com.ua/archive/2006/N11/art_05.htm (in Russian).
5. Young P. Pharmaceutical companies of all countries, unite! Provizor 2006; (2). Available from: http://www.provisor.com.ua/archive/2006/N2/art_04.htm (in Russian).
6. Mossialos E, Mravek M, Wally T, eds. Regulating pharmaceuticals in Europe: striving for efficiency, equity and quality. The European Observatory on Health Systems. Open University Press, ÂÎÇ; 2004 (in Russian).
7. Glumskov V. World pharmaceutical market: state and development trends. Ekspert — Kazakhstan 2007; 20(122). Available from: http://www.expert.ru/printissues/kazakhstan/2007/20/mirovoy_farmacevticheskiy_rynok (in Russian).
8. Pashutin S. Offshore for substances. Himicheskiy zhurnal 2005; (12): 36–38 (in Russian).
9. Chownhan T. Pharmacopeial harmonization: a progress report. Drug Information Journal 1996; 30: 451–9.
10. Hutton RC. Harmonization of pharmacopoeial monographs and test methods. Drug Information Journal 1999; 33(1): 297–301. Available from: http://findarticles.com/p/articles/mi_qa3899/is_1999901/ai_n8846609.
11. Bandurin VV, Rachich B, Chatich M. Globalization of the world economy and Russia. Moscow: Bukvitsa; 1999 (in Russian).
12. Vladimirova IG. Globalization of the World Economy: Challenges and Implications. Korporativny menedzhment 2001; (3): 97–111 (in Russian).
13. Index of pharmacopoeias. WHO/EDM/QSM/2002.6
14. Index of pharmacopoeias. WHO/PSM/QSM/2006.6
15. Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. WHO; 2001.
16. The Status of traditional medicine in Africa and review of progress made on the implementation of the plan of action on the African union decade of traditional medicine (2001–2010). Third session of the African union conference of ministers of health 9–13 April 2007, Johannesburg, South Africa. Available from: http://www.africa-union.org/root/ua/conferences/2007/avril/SA/9-13%20avr/doc/en/TRADITIONAL_MEDICINE_MINo._DRAFT.pdf
17. Strengthening of Health Systems for Equity and Development in Africa. The status of traditional medicine in Africa and review of progress made on the implementation of the plan of action on the African union decade of traditional medicine (2001– 2010). Third session of the African union conference of ministers of health, 9–13 April 2007, Johannesburg, South Africa.
18. Ebrahimnejad H. Religion and medicine in Iran: from relationship to dissociation. Hist. Sci. 2002; 40, 91–112. Available from: http://www.shpltd.co.uk/ebrahim-religion.pdf.
19. United States Pharmacopoeia 39 and National Formulary 34. Available from: http://www.usp.org/usp-nf.
20. European Pharmacopoeia. 8th ed. Available from: http://online.edqm.eu/entry.htm.
21. British Pharmacopoeia. London; 2015.
22. Georgievsky VP. Development of the State Pharmacopoeia of Ukraine I edition. Provizor 1998: (11). Available from: http://www.provisor.com.ua/archive/1998/N11/pharmakop.php (in Russian).
23. Tulegenova AU. Kazakhstan. Creation of the State Pharmacopoeia of the Republic— an urgent demand of the time. Remedium 2007; 10: 62–65 (in Russian).
24. Swarburck J, Boglan JC, eds. Encyclopedia of Pharmaceutical Technology. 2nd ed. 2002.
25. Williams RL. US Pharmacopoeia’s International activities. Pharmaceutical Technology 2005; 29(7): 68–69.
26. US Pharmacopeia inaugurates new facility in Shanghai. BioSpectrum-Pharma. Available from: http://www.biospectrumasia.com/content/070907CHN4296.asp.
27. USA Pharmacopeia setting up branch in Zhangjiang, PUDONG, Economic news, 28.11.2006. Available from: http://www.pudong.gov.cn/english/common/conent.jsp?sj_id=112&ct_id=121128.
28. Etkin NL. A Hausa herbal pharmacopoeia: biomedical evaluation of commonly used plant medicines. J. Ethnopharmacol 1981; 4(1):75–98.
29. Revised Herbal Pharmacopoeia launched. Available from: http://www.ghanaweb.com/GhanaHomePage/NewsArchive/artikel.php?ID=128663.
30. Indian Pharma makes an inroad into Japan. Express Healthcare Management, 16_–_30 September 2005.
31. International Pharmacopoeia. 5-th ed. 2015. Available from: http://www.who.int/medicines/publications/pharmacopoeia/en/.
32. Arzamastsev AP. «Entrance ticket» for drugs. Meditsinskaya gazeta 2003; (47) (in Russian).
33. Convention on the Elaboration of a European Pharmacopoeia Strasbourg, 22.VII.1964. Available from: http://conventions.coe.int/Treaty/en/Treaties/Html/050.htm.
34. Cavaliere C. New Organization to Develop Quality Standards for African Herbs. Herbal Gram. 2006; 70: 24–25.
35. Hopes of an African herbal pharmacopeia look bright. Press release, July 2007. Available from: http://www.sputtr.com/aamps.
36. African Traditional Medicine Day. The African Health monitoring 2010, special issue 31 August, World Health Organization Regional Office for Africa.
37. Asian Crude Drugs. Their Preparations and Specifications: Asian Pharmacopoeia; 1977.
38. Asian Crude Drugs. Their Preparations and Specifications: Asian Pharmacopoeia (FAPA). Available from: http://www.japic.or.jp/service/library/cou_official.html.
39. The Executive Committee of the Commonwealth of Independent States. Issues discussed at the meeting. Available from: http://www.cis.minsk.by/main.aspx?uid=7944 1.
40. In Bishkek, discusses the creation of the Pharmacopoeia of the EurAsEC member states. News agency PRESS-UZ.info. Available from: http://www.press- uz.info/index.php?title=home&nid=3980&my=102007 (in Russian).
41. State of work of International harmonization. International Harmonisation. PHARMEUROPA 2008; 20(1): 163.
42. Dictionary of economic terms. Available from: http://www.bank24.ru/info/glossary /?ch=%CE&word=1471 (in Russian).
43. Pharmacopoeial discussion group statement of harmonization policy. International Harmonisation. PHARMEUROPA 2004; 16(3): 448.
44. Working Procedures of the Pharmacopoeial Discussion Group (Revised Version). EDQM. European Pharmacopoeia Commission PA/PH/SG (07) 53, Strasbourg, November 2007. Available from: http://www.edqm.eu/medias/fishiers/pdf_working_procedures.pdf.
45. The impact of the use of guidelines of the International Conference on Harmonisation (ICH) in countries that are not participating in the ICG. Geneva: World Health Organization; 2002 (in Russian).
46. History and future of ICH. Available from: http://ich.org.
47. Structure of ICH. Available from: http://ich.org.
48. The ICH process for harmonisation of guidelines. Available from: http://ich.org.
49. International Pharmaceutical Excipients Council. Available from: http://www.ipec.org.
50. Molzon JA. Current International Harmonization Efforts: Opportunities and Challenges. Report. AAPS Workshop: Pharmaceutical stability testing to support global markets general session B: global stability testing requirements, September 11, 2007. Available from: http://www.aapspharmaceutica.com/meetings/files/100/ UPLOADJustinaMolzon CurrentInternational Harmonization.pdf.
51. DOC IV-8 WG/PHARMACOPOEIA. Report and Proposal. IV PAN American conference for drug regulatory harmonization. Dominican Republic, 2–4 March 2005.
52. Becerril CM, Bittencourt CF, Feter E, Chole C, Willams RL. Review of the Pharmacopeial Processes in the Americas: Argentina, Brazil, Mexico and the United States. Available from: http://www.paho.org/english/ad/ths/ev/Pharmaco_poster.pdf.
53. Artiges A. The role of pharmacopoeias in international harmonization. J Pharm Biomed Analysis 2001, 5–6(24); 769–72.
54. State Pharmacopoeia of the Republic of Belarus. 2nd ed. V._1 and 2. Minsk; 2012 (in Russian).
55. State Pharmacopoeia of Ukraine. 1st ed. Kharkov; 2004. Appendix 3; 2010 (in Russian).
56. Derimedved LV, Pertsev IM, Musienko RS. The factors that determine the effectiveness of medicines. Provizor 2003; (9). Available from: http://www.provisor.com.ua/archive/2003/N9/art_06/htm (in Russian).
57. Kim K, Johnson JA, Derendorf H. Differences in Drug Pharmacokinetics Between East Asians and Caucasians and the Role of Genetic Polymorphisms. J. Clin. Pharmacol. 2004; 10(44), 1083–1105.
58. The first global summit of Pharmacopoeias, November 17–18, 2011, Beijing. Available from: http://pharmapractice.ru/50659 (in Russian).
Review
For citations:
Titova A.V., Sadchikova N.P. The role of pharmacopoeia in the context of globalization of world economies and its development prospects. The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2016;(2):42-49. (In Russ.)
Views:
7522
Email this article 